Cargando…
Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study
Cancer is the leading cause of death in dogs, yet there are no established screening paradigms for early detection. Liquid biopsy methods that interrogate cancer-derived genomic alterations in cell-free DNA in blood are being adopted for multi-cancer early detection in human medicine and are now ava...
Ejemplares similares
-
Blood-Based Liquid Biopsy for Comprehensive Cancer Genomic Profiling Using Next-Generation Sequencing: An Emerging Paradigm for Non-invasive Cancer Detection and Management in Dogs
por: Kruglyak, Kristina M., et al.
Publicado: (2021) -
Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs
por: Chibuk, Jason, et al.
Publicado: (2021) -
Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs
por: Flory, Andi, et al.
Publicado: (2023) -
Prevalence of Reproductive Disorders including Mammary Tumors and Associated Mortality in Female Dogs
por: Beaudu-Lange, Claire, et al.
Publicado: (2021) -
Cell‐free DNA screening in twin pregnancies: A more accurate and reliable screening tool
por: Chibuk, Jason, et al.
Publicado: (2020)